We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · August 26, 2021

Effect of Rivaroxaban and Aspirin in Patients With PAD Undergoing Surgical Revascularization



Additional Info

Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial
Circulation 2021 Aug 12;[EPub Ahead of Print], ES Debus, MR Nehler, N Govsyeyev, RM Bauersachs, SS Anand, MR Patel, F Fanelli, WH Capell, T Brackin, F Hinterreiter, D Krievins, P Nault, G Piffaretti, A Svetlikov, N Jaeger, CN Hess, HH Sillesen, M Conte, J Mills, E Muehlhofer, LP Haskell, SD Berkowitz, WR Hiatt, MP Bonaca

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading